Rimma Lebedev

Title: Rimma Lebedev: Innovator in RXR Agonist Research

Introduction

Rimma Lebedev is a notable inventor based in Basking Ridge, NJ (US). He has made significant contributions to the field of pharmacology, particularly in the development of RXR agonists for treating various metabolic disorders. With a total of 3 patents, his work is paving the way for innovative treatments in dyslipidemia, hypercholesterolemia, and diabetes.

Latest Patents

Rimma's latest patents include groundbreaking compounds that serve as RXR agonists. The first patent focuses on Dihydro-[1H]-quinolin-2-one derivatives, which are designed for the treatment of dyslipidemia, hypercholesterolemia, and diabetes. This invention encompasses compounds of Formula (I), methods for preparing these compounds, and their applications in treating RXR mediated disorders. The second patent also centers on heterocyclic amide derivatives, similarly aimed at addressing RXR mediated disorders through innovative compounds.

Career Highlights

Rimma Lebedev is currently associated with Janssen Pharmaceutica NV, where he continues to advance his research in pharmacological innovations. His work is characterized by a commitment to developing effective treatments that target critical health issues.

Collaborations

Rimma collaborates with esteemed colleagues, including Bharat Lagu and Barbara A Pio, who contribute to the dynamic research environment at Janssen Pharmaceutica NV. Their collective expertise enhances the potential for groundbreaking discoveries in the field.

Conclusion

Rimma Lebedev's contributions to RXR agonist research exemplify the impact of innovative thinking in medicine. His patents and ongoing work at Janssen Pharmaceutica NV highlight the importance of collaboration and dedication in advancing healthcare solutions.